|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 155.6 SEK | +4.57% |
|
+2.91% | -14.74% |
| Apr. 15 | Gisli Hennermark to Leave His Position as CEO of Surgical Science Sweden AB | CI |
| Mar. 12 | Surgical Science Sweden to Step Down; Search for Successor Starts | MT |
Surgical Science Sweden AB (publ) reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was SEK 366.78 million compared to SEK 104.8 million a year ago. Net income was SEK 86.25 million compared to SEK 15.61 million a year ago.
Basic earnings per share from continuing operations was SEK 2.03 compared to SEK 0.45 a year ago. Diluted earnings per share from continuing operations was SEK 2.02 compared to SEK 0.45 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -14.74% | 693M | |
| +5.54% | 32.47B | |
| +16.51% | 7.45B | |
| +23.49% | 3.89B | |
| -15.47% | 3.17B | |
| -25.99% | 1.28B | |
| -33.58% | 1.09B | |
| -33.74% | 902M | |
| +1.39% | 893M | |
| -25.64% | 857M |
SURGICAL SCIENCE SWEDEN AB 
